Julie Bolcaen

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 8

Top Venues

Pharmaceuticals (Basel, Switzerland)

PloS one

Cancers

Animals : an open access journal from MDPI

iThemba LABS

Universiteit Gent (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

iThemba LABS May 19 2019

South Africa

Postdoctoral researcher Radiobiology :: Radiobiology

Universitair Ziekenhuis Gent Oct 01 2011 - Sep 30 2017

Belgium

Assistant PhD :: Radiology and Nuclear Medicine

Education History

Universiteit Gent

Belgium

MSC

Publications

Charnay Cunningham, Julie Bolcaen, Alessandra Bisio, Amanda Genis, Hans Strijdom, Charlot Vandevoorde
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Amèlia Jansen van Vuuren, Julie Bolcaen, Monique Engelbrecht, Willem Burger, Maryna De Kock, Marco Durante, Randall Fisher, Wilner Martínez-López, Xanthene Miles, Farzana Rahiman, Walter Tinganelli, Charlot Vandevoorde
Establishment of Primary Adult Skin Fibroblast Cell Lines from African Savanna Elephants ( Loxodonta africana ). Animals : an open access journal from MDPI 13 (14) (2023)
Liesbeth Everix, Elsie Neo Seane, Thomas Ebenhan, Ingeborg Goethals, Julie Bolcaen
Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Liesbeth Everix, Shankari Nair, Cathryn H S Driver, Ingeborg Goethals, Machaba Michael Sathekge, Thomas Ebenhan, Charlot Vandevoorde, Julie Bolcaen
Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma. Cancers 14 (7) (2022)
Julie Bolcaen, Benedicte Descamps, Karel Deblaere, Filip De Vos, Tom Boterberg, Giorgio Hallaert, Caroline Van den Broecke, Christian Vanhove, Ingeborg Goethals
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI. PloS one 16 (3) (2021)
Julie Bolcaen, Shankari Nair, Cathryn H S Driver, Tebatso M G Boshomane, Thomas Ebenhan, Charlot Vandevoorde
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Shankari Nair, Monique Engelbrecht, Xanthene Miles, Roya Ndimba, Randall Fisher, Peter du Plessis, Julie Bolcaen, Jaime Nieto-Camero, Evan de Kock, Charlot Vandevoorde
The Impact of Dose Rate on DNA Double-Strand Break Formation and Repair in Human Lymphocytes Exposed to Fast Neutron Irradiation. International journal of molecular sciences 20 (21) (2019)
Julie Bolcaen, Kelly Lybaert, Lieselotte Moerman, Benedicte Descamps, Karel Deblaere, Tom Boterberg, Jean-Pierre Kalala, Caroline Van den Broecke, Filip De Vos, Christian Vanhove, Ingeborg Goethals
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats. PloS one 11 (8) (2016)

Julie Bolcaen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Julie Bolcaen